
Hepta Medical
Develops a minimally invasive, non-surgical treatment method for early-stage cancers.
Date | Investors | Amount | Round |
---|---|---|---|
* | €5.7m | Series A | |
Total Funding | 000k |
Related Content
HEPTA Medical specializes in the development of advanced microwave ablation catheters designed to enhance the predictability and safety of interventional oncology procedures. The company's core product integrates tissue temperature sensing technology, allowing for real-time monitoring and control of tissue ablation. This innovation aims to improve patient outcomes by ensuring precise lesion size control, thereby reducing the risk of local recurrence post-operation. HEPTA Medical primarily serves the healthcare sector, focusing on interventional oncology professionals who require reliable and efficient ablation solutions. The business operates within the medical device market, leveraging its technology to address critical safety margins in oncology treatments. Revenue generation is likely driven by the sale and distribution of its specialized catheters, supported by ongoing prototyping and development efforts following a successful seed financing round.
Keywords: microwave ablation, tissue sensing, oncology, catheter, interventional, safety, lesion control, healthcare, prototyping, financing.